Previous research show that the activation of the PKC/Noxsignaling complex regulates ROS levels and is involved in various pathophysiological conditions [17], also related to oxidative stress, such as Parkinson disease [50], atherosclerosis [51] and hypertension [52]. This evidence concerns the gene PRRT2 and atherosclerosis.